Early research (Phase 1)Study completedNCT02031198
What this trial is testing
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Axon Neuroscience SE 25
Showing 20 of 290 results